139
Views
23
CrossRef citations to date
0
Altmetric
Letters to the Editor

Presence of Hoechst low side populations in multiple myeloma

, , , , , , & show all
Pages 1813-1816 | Received 01 Dec 2007, Accepted 13 Jun 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alessandro Allegra, Andrea Alonci, Giuseppa Penna, Vanessa Innao, Demetrio Gerace, Francesco Rotondo & Caterina Musolino. (2014) The Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets. Cancer Investigation 32:9, pages 470-495.
Read now
Ben-Zion Katz. (2008) Side populations–following the footprints of the elusive multiple myeloma stem cells?. Leukemia & Lymphoma 49:9, pages 1657-1658.
Read now

Articles from other publishers (21)

Stefan Forster, Ramin Radpour & Adrian F. Ochsenbein. (2023) Molecular and immunological mechanisms of clonal evolution in multiple myeloma. Frontiers in Immunology 14.
Crossref
S. Rajeev Krishnan & M. Bebawy. (2023) Circulating biosignatures in multiple myeloma and their role in multidrug resistance. Molecular Cancer 22:1.
Crossref
Harish Kumar, Suman Mazumder, Neeraj Sharma, Sayak Chakravarti, Mark D. Long, Nathalie Meurice, Joachim Petit, Song Liu, Marta Chesi, Sabyasachi Sanyal, A. Keith Stewart, Shaji Kumar, Leif Bergsagel, S. Vincent Rajkumar, Linda B. Baughn, Brian G. Van Ness & Amit Kumar Mitra. (2022) Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells. Frontiers in Oncology 12.
Crossref
Kentaro Serizawa, Hirokazu Tanaka, Takeshi Ueda, Ayano Fukui, Hiroaki Kakutani, Takahide Taniguchi, Hiroaki Inoue, Takahiro Kumode, Yasuhiro Taniguchi, Shinya Rai, Chikara Hirase, Yasuyoshi Morita, J. Luis Espinoza, Yoichi Tatsumi, Takashi Ashida & Itaru Matsumura. (2022) CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence. International Journal of Hematology 115:3, pages 336-349.
Crossref
Wancheng Guo, Haiqin Wang, Peng Chen, Xiaokai Shen, Boxin Zhang, Jing Liu, Hongling Peng & Xiaojuan Xiao. (2021) Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. Cancers 13:14, pages 3523.
Crossref
Franco Dammacco, Patrizia Leone, Franco Silvestris, Vito Racanelli & Angelo Vacca. 2019. Oncogenomics. Oncogenomics 121 137 .
Na Jin, Xiaojian Zhu, Fanjun Cheng & Liling Zhang. (2018) Disulfiram/copper targets stem cell‐like ALDH + population of multiple myeloma by inhibition of ALDH1A1 and Hedgehog pathway . Journal of Cellular Biochemistry 119:8, pages 6882-6893.
Crossref
Minjie Gao, Yuanyuan Kong, Guang Yang, Lu Gao & Jumei Shi. (2016) Multiple myeloma cancer stem cells. Oncotarget 7:23, pages 35466-35477.
Crossref
Reinaldo Franqui-Machin, Erik B. Wendlandt, Siegfried Janz, Fenghuang Zhan & Guido Tricot. (2015) Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?. Oncotarget 6:38, pages 40496-40506.
Crossref
Juan Du, Shuyan Liu, Jie He, Xi Liu, Ying Qu, Wenqing Yan, Jianling Fan, Rong Li, Hao Xi, Weijun Fu, Chunyang Zhang, Jing Yang & Jian Hou. (2015) MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma. Oncotarget 6:17, pages 14993-15007.
Crossref
Masahiro Abe, Takeshi Harada & Toshio Matsumoto. (2014) Concise Review: Defining and Targeting Myeloma Stem Cell‐Like Cells. STEM CELLS 32:5, pages 1067-1073.
Crossref
Yue-Yu Gu, Li-Ping Liu, Jian Qin, Meng Zhang, Yuling Chen, Dongmei Wang, Zhi Li, Jing-Zhong Tang & Sui-Lin Mo. (2014) Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro. Fitoterapia 94, pages 21-28.
Crossref
Yuling Chen, Sui-Lin Mo, Felix Wu Shun Wong, George Qian Li, Yen Siew Loh, Basil D. Roufogalis, Maureen V. Boost & Daniel Man-Yuen Sze. (2014) Factors Influencing Percentage Yield of Side Population Isolated in Ovarian Cancer Cell LineSK-OV-3. Journal of Cancer Research Updates 3:1, pages 42-58.
Crossref
Mei-Gui Lin, Li-Ping Liu, Chen-Yin Li, Meng Zhang, Yuling Chen, Jian Qin, Yue-Yu Gu, Zhi Li, Xin-Lin Wu & Sui-Lin Mo. (2013) Scutellaria Extract Decreases the Proportion of Side Population Cells in a Myeloma Cell Line by Down-regulating the Expression of ABCG2 Protein. Asian Pacific Journal of Cancer Prevention 14:12, pages 7179-7186.
Crossref
Roman Hajek, Samuel A. Okubote & Hana Svachova. (2013) Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma. British Journal of Haematology 163:5, pages 551-564.
Crossref
Ross BrownKarieshma KabaniJames FavaloroShihong YangP. Joy HoJohn GibsonPhillip Fromm, Hayley SuenNarelle Woodland, Najah Nassif, Derek Hart & Douglas Joshua. (2012) CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis. Blood 120:10, pages 2055-2063.
Crossref
A Ikegame, S Ozaki, D Tsuji, T Harada, S Fujii, S Nakamura, H Miki, A Nakano, K Kagawa, K Takeuchi, M Abe, K Watanabe, M Hiasa, N Kimura, Y Kikuchi, A Sakamoto, K Habu, M Endo, K Itoh, H Yamada-Okabe & T Matsumoto. (2012) Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors. Leukemia 26:9, pages 2124-2134.
Crossref
Kudaravalli Jyothsna. (2012) Development of cell culture samples for drug screening with bone marrow stem cells. Apollo Medicine 9:2, pages 91-95.
Crossref
Sui-Lin Mo, Jia Li, Yen S. Loh, Ross D. Brown, Adrian L. Smith, Yuling Chen, Douglas Joshua, Basil D. Roufogalis, George Q. Li, Kei Fan, Michelle C. H. Ng & Daniel Man-yuen Sze. (2011) Factors Influencing the Abundance of the Side Population in a Human Myeloma Cell Line. Bone Marrow Research 2011, pages 1-8.
Crossref
Jana JakubikovaSophia Adamia, Maria Kost-Alimova, Steffen KlippelDavid CerviJohn F. Daley, Dana CholujovaSun-Young KongMerav LeibaSimona BlottaMelissa OoiJake DelmoreJacob LaubachPaul G. RichardsonJan SedlakKenneth C. AndersonConstantine S. Mitsiades. (2011) Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications. Blood 117:17, pages 4409-4419.
Crossref
Daniel Man‐Yuen Sze, Jian Hou & Lily Zhou. (2008) Newly developed effective anti‐cancer drugs targeting multiple myeloma. Drug Development Research 69:7, pages 451-459.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.